Evidence map›Paper›PMID 36330429›Full record

ArticleFrontiers in neurology2022

Longitudinal evaluation of olfactory function in individuals with Gaucher disease and

Grisel J Lopez, Jens Lichtenberg, Nahid Tayebi, Emory Ryan, Abigail L Lecker, Ellen Sidransky

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Olfactory Perception in Parkinson's Disease: The Impact ofInternational journal of molecular sciences · 2025
    Article
  3. Skin α-Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease.Movement disorders : official journal of the Movement Disorder Society · 2024
    Article
  4. Review
  5. International journal of molecular sciences · 2024
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Grisel J LopezMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Jens LichtenbergMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Nahid TayebiMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Emory RyanMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Abigail L LeckerMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.
Ellen SidranskyMedical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Biallelic mutations in Methods: One hundred seventeen individuals who participated in a natural history study of GD at the National Institutes of Health were evaluated using the University of Pennsylvania Smell Identification Test (UPSIT) during a 16-year period. Seventy patients with GD (13 with PD) and 47 Results: Severe hyposmia and anosmia was evident in both

Indexed as

Gaucher diseaseGBA1glucocerebrosidaseParkinson'sprodromal

Identifiers

PMID36330429
PMCPMC9622935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.